Skip to main content
Equibles

VANGUARD ASSET MANAGEMENT, Ltd

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1680208 London, EC4N 8AF, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,613,787
+$320,188 QoQ
Shares Held
439,724
+4.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 344 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VANGUARD ASSET MANAGEMENT, Ltd holds $992,377,564 across 155 Biotechnology names. RXRX ranks #64 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 494,186 $245,477,011
2 REGN
Regeneron Pharmaceuticals, Inc.
 197,770 $123,317,505
3 ALNY
Alnylam Pharmaceuticals, Inc.
 257,710 $77,578,441
4 RPRX
Royalty Pharma plc
 932,544 $52,287,742
5 INSM
INSMED Inc
 416,108 $44,365,434
6 INCY
Incyte Corp
 335,081 $37,984,782
7 MRNA
Moderna, Inc.
 330,089 $23,116,132
8 RVMD
Revolution Medicines, Inc.
 92,056 $17,240,247

All Filings in RXRX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,613,787 439,724
2026-03-31 $1,293,599 421,368